ResearcherMedical University of South CarolinaActive in the last 2 years
Richard R. Drake
Matched on ORCID iD 0000-0002-6285-6440; OpenAlex author ID A5047946163. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 25
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Multi-modal spatial glycomic analysis of lymphoid aggregates in prostate and pancreatic cancer tissues. Last author DOI 10.3389/fonc.2026.1935795↗
- Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues. Last author DOI 10.1074/mcp.ra120.002256↗
- Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. Co-author DOI 10.1158/1078-0432.ccr-20-2475↗
- The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. Co-author DOI 10.1158/1078-0432.ccr-18-3310↗
- The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. Co-author DOI 10.1038/s41598-017-04164-z↗
- LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria. Co-author DOI 10.1124/jpet.112.199216↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Brian B. Haab · 4 shared papers, 2017–2021 · strength 0.37
- Paper Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tis… DOI 10.1074/mcp.ra120.002256↗
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Colin T. McDowell · 2 shared papers, 2021–2026 · strength 0.37
- Daniel Barnett · 3 shared papers, 2017–2021 · strength 0.25
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Paper The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. DOI 10.1038/s41598-017-04164-z↗
- Randall E. Brand · 3 shared papers, 2017–2021 · strength 0.25
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Paper The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. DOI 10.1038/s41598-017-04164-z↗
- Aatur Dilip Singhi · 3 shared papers, 2017–2021 · strength 0.25
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Paper The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. DOI 10.1038/s41598-017-04164-z↗
- Ying Huang · 3 shared papers, 2017–2021 · strength 0.25
- Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
- Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
- Paper The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. DOI 10.1038/s41598-017-04164-z↗
- Blake E. Sells · 1 shared paper, 2026 · strength 0.24
- Liang‐I Kang · 1 shared paper, 2026 · strength 0.24
- Kameisha V. Rashford · 1 shared paper, 2026 · strength 0.24
- Joseph E. Ippolito · 1 shared paper, 2026 · strength 0.24
- David G DeNardo · 1 shared paper, 2026 · strength 0.24
- Luke Wisniewski · 2 shared papers, 2021 · strength 0.22
- Ben Staal · 2 shared papers, 2019–2021 · strength 0.18
- ChongFeng Gao · 2 shared papers, 2019–2021 · strength 0.18
- Ying Liu · 2 shared papers, 2017–2021 · strength 0.17
- Peter J. Allen · 1 shared paper, 2021 · strength 0.10
- Amer H. Zureikat · 1 shared paper, 2021 · strength 0.10
- Mohammed Aldakkak · 1 shared paper, 2021 · strength 0.10
- Douglas B. Evans · 1 shared paper, 2021 · strength 0.10
- Susan Tsai · 1 shared paper, 2021 · strength 0.10
- David Arthur Tuveson · 1 shared paper, 2021 · strength 0.10
- Anirban Maitra · 1 shared paper, 2019 · strength 0.08
- Xiang Liu · 1 shared paper, 2013 · strength 0.03
- Thomas Hendrix Beckham · 1 shared paper, 2013 · strength 0.03
- Clayton S. Lewis · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.